Burden of influenza A (H1N1)pdm09 infection among tuberculosis patients : a prospective cohort study
© 2023. BioMed Central Ltd., part of Springer Nature..
BACKGROUND: Influenza and tuberculosis both cause significant morbidity and mortality worldwide. Therefore, this study aimed to estimate the burden of influenza A (H1N1)pdm09 virus infection among human tuberculosis patients and the general population.
METHODS: A prospective cohort study was conducted among a cohort group (TB positive patients) as exposed and a comparison group (general population) as non-exposed. A total of 304 participants were recruited in both groups and followed for a period of 12 weeks. Of the 304 concurrently enrolled individuals, 152 were TB-positive patients (cohort group) and 152 were from the general population (comparison group).To calculate the sample size, the power of study was kept at 80% for detecting a difference at 5% alpha level assuming the 25% prevalence of respiratory viruses in cohort group compared to 12.5% in general population. An oropharyngeal swab was taken from a participant with symptoms of influenza-like illness (ILI). Samples were tested by conventional reverse transcription polymerase chain reaction (RT-PCR) for the detection of influenza A (H1N1)pdm09. All statistical analyses were conducted using R software.
RESULTS: A total of 95 participants developed influenza-like illness (ILI) symptoms. Among these, 64 tested positive for influenza A(H1N1)pdm09, of which 39 were from the exposed group and 25 were from the non-exposed group. During the 12-week period of follow-up, the influenza A (H1N1)pdm09 incidence rate was 20 per 1000 people. The risk of testing positive for influenza A (H1N1)pdm09 was 1.66 times higher in the exposed group compared to the non-exposed group. The cumulative incidence indicated that 25% of the TB cohort and 16% of the comparison group were at risk of getting influenza A (H1N1)pdm09 during the 12 weeks of follow-up.
CONCLUSION: Participants from the TB cohort had a higher incidence of influenza A (H1N1)pdm09 than the general population suggesting that they should be prioritized for influenza vaccination.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
BMC infectious diseases - 23(2023), 1 vom: 10. Aug., Seite 526 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Umbreen, Gulshan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cohort studies |
---|
Anmerkungen: |
Date Completed 14.08.2023 Date Revised 21.11.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s12879-023-08441-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM360630960 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM360630960 | ||
003 | DE-627 | ||
005 | 20231226083426.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12879-023-08441-3 |2 doi | |
028 | 5 | 2 | |a pubmed24n1202.xml |
035 | |a (DE-627)NLM360630960 | ||
035 | |a (NLM)37563563 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Umbreen, Gulshan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Burden of influenza A (H1N1)pdm09 infection among tuberculosis patients |b a prospective cohort study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.08.2023 | ||
500 | |a Date Revised 21.11.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. BioMed Central Ltd., part of Springer Nature. | ||
520 | |a BACKGROUND: Influenza and tuberculosis both cause significant morbidity and mortality worldwide. Therefore, this study aimed to estimate the burden of influenza A (H1N1)pdm09 virus infection among human tuberculosis patients and the general population | ||
520 | |a METHODS: A prospective cohort study was conducted among a cohort group (TB positive patients) as exposed and a comparison group (general population) as non-exposed. A total of 304 participants were recruited in both groups and followed for a period of 12 weeks. Of the 304 concurrently enrolled individuals, 152 were TB-positive patients (cohort group) and 152 were from the general population (comparison group).To calculate the sample size, the power of study was kept at 80% for detecting a difference at 5% alpha level assuming the 25% prevalence of respiratory viruses in cohort group compared to 12.5% in general population. An oropharyngeal swab was taken from a participant with symptoms of influenza-like illness (ILI). Samples were tested by conventional reverse transcription polymerase chain reaction (RT-PCR) for the detection of influenza A (H1N1)pdm09. All statistical analyses were conducted using R software | ||
520 | |a RESULTS: A total of 95 participants developed influenza-like illness (ILI) symptoms. Among these, 64 tested positive for influenza A(H1N1)pdm09, of which 39 were from the exposed group and 25 were from the non-exposed group. During the 12-week period of follow-up, the influenza A (H1N1)pdm09 incidence rate was 20 per 1000 people. The risk of testing positive for influenza A (H1N1)pdm09 was 1.66 times higher in the exposed group compared to the non-exposed group. The cumulative incidence indicated that 25% of the TB cohort and 16% of the comparison group were at risk of getting influenza A (H1N1)pdm09 during the 12 weeks of follow-up | ||
520 | |a CONCLUSION: Participants from the TB cohort had a higher incidence of influenza A (H1N1)pdm09 than the general population suggesting that they should be prioritized for influenza vaccination | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cohort studies | |
650 | 4 | |a Humans | |
650 | 4 | |a Incidence | |
650 | 4 | |a Influenza | |
650 | 4 | |a Prospective studies | |
650 | 4 | |a Tuberculosis | |
650 | 4 | |a Viruses | |
700 | 1 | |a Rehman, Abdul |e verfasserin |4 aut | |
700 | 1 | |a Avais, Muhammad |e verfasserin |4 aut | |
700 | 1 | |a Jabeen, Chanda |e verfasserin |4 aut | |
700 | 1 | |a Sadiq, Shakera |e verfasserin |4 aut | |
700 | 1 | |a Maqsood, Rubab |e verfasserin |4 aut | |
700 | 1 | |a Rashid, Hamad Bin |e verfasserin |4 aut | |
700 | 1 | |a Afzal, Saira |e verfasserin |4 aut | |
700 | 1 | |a Chaudhry, Mamoona |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC infectious diseases |d 2001 |g 23(2023), 1 vom: 10. Aug., Seite 526 |w (DE-627)NLM11120089X |x 1471-2334 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2023 |g number:1 |g day:10 |g month:08 |g pages:526 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12879-023-08441-3 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 23 |j 2023 |e 1 |b 10 |c 08 |h 526 |